These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
420 related articles for article (PubMed ID: 15350937)
1. Adjuvant therapy for pancreatic cancer: an evolving paradigm. Zhu AX; Clark JW; Willett CG Surg Oncol Clin N Am; 2004 Oct; 13(4):605-20, viii. PubMed ID: 15350937 [TBL] [Abstract][Full Text] [Related]
2. Conclusions from the European Study Group for Pancreatic Cancer adjuvant trial of chemoradiotherapy and chemotherapy for pancreatic cancer. Ghaneh P; Neoptolemos JP Surg Oncol Clin N Am; 2004 Oct; 13(4):567-87, vii-viii. PubMed ID: 15350935 [TBL] [Abstract][Full Text] [Related]
3. Adjuvant therapy following resection for pancreatic adenocarcinoma. Brennan MF Surg Oncol Clin N Am; 2004 Oct; 13(4):555-66, vii. PubMed ID: 15350934 [TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant therapy for pancreatic cancer: the Duke experience. White RR; Tyler DS Surg Oncol Clin N Am; 2004 Oct; 13(4):675-84, ix-x. PubMed ID: 15350941 [TBL] [Abstract][Full Text] [Related]
5. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy]. Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156 [TBL] [Abstract][Full Text] [Related]
6. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma. O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737 [TBL] [Abstract][Full Text] [Related]
7. The case for routine use of adjuvant therapy in pancreatic cancer. Kennedy EP; Yeo CJ J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543 [TBL] [Abstract][Full Text] [Related]
8. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival. Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382 [TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant therapy for resectable pancreatic cancer. Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939 [TBL] [Abstract][Full Text] [Related]
10. Does intraoperative radiation therapy improve local tumor control in patients undergoing pancreaticoduodenectomy for pancreatic adenocarcinoma? A propensity score analysis. Showalter TN; Rao AS; Rani Anne P; Rosato FE; Rosato EL; Andrel J; Hyslop T; Xu X; Berger AC Ann Surg Oncol; 2009 Aug; 16(8):2116-22. PubMed ID: 19437078 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
13. Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium. Miller RC; Iott MJ; Corsini MM Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):364-8. PubMed ID: 19735864 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant therapy for pancreatic cancer: current status and future directions. Xiong HQ; Abbruzzese JL Surg Oncol Clin N Am; 2004 Oct; 13(4):737-49, xi. PubMed ID: 15350945 [TBL] [Abstract][Full Text] [Related]
15. The multidisciplinary management of gastrointestinal cancer. Pancreatic cancer: from pathogenesis to cure. Ducreux M; Boige V; Goéré D; Deutsch E; Ezra P; Elias D; Malka D Best Pract Res Clin Gastroenterol; 2007; 21(6):997-1014. PubMed ID: 18070700 [TBL] [Abstract][Full Text] [Related]
16. Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003. Abrams RA; Yeo CJ Surg Oncol Clin N Am; 2004 Oct; 13(4):621-38, ix. PubMed ID: 15350938 [TBL] [Abstract][Full Text] [Related]
17. The Virginia Mason approach to localized pancreatic cancer. Picozzi VJ; Traverso LW Surg Oncol Clin N Am; 2004 Oct; 13(4):663-74, ix. PubMed ID: 15350940 [TBL] [Abstract][Full Text] [Related]
18. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment. Artinyan A; Hellan M; Mojica-Manosa P; Chen YJ; Pezner R; Ellenhorn JD; Kim J Cancer; 2008 Jan; 112(1):34-42. PubMed ID: 18000805 [TBL] [Abstract][Full Text] [Related]
19. Cisplatin, fluorouracil, interferon-alpha, and radiation as adjuvant therapy for resected pancreatic cancer: is there a future for this regimen and/or should we change our approach to research and treatment of patients with pancreatic cancer? Pisters PW; Evans DB Ann Surg; 2008 Aug; 248(2):152-3. PubMed ID: 18650622 [No Abstract] [Full Text] [Related]
20. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Kosuge T; Kiuchi T; Mukai K; Kakizoe T; Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]